Oxytocin

Therapeutic Solutions International Reports Superior Neurogenesis Induction in Animal Model of Viral Induced Cognitive Dysfunction Compared to other Stem Cell Types

Retrieved on: 
Wednesday, August 11, 2021

The process of producing new brain cells is termed "neurogenesis" and is an active area of research for the Company.

Key Points: 
  • The process of producing new brain cells is termed "neurogenesis" and is an active area of research for the Company.
  • "We saw that increasing doses of double stranded RNA, which mimics viral induced inflammation, was associated with decreased neurogenesis, which is to be expected.
  • In previous studies the Company has demonstrated the superior activity of JadiCell to other types of stem cells including bone marrow, adipose, cord blood, and placenta.
  • Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.

It's Dog Parent Appreciation Day, Here Are 5 Vet-Recommended Ways to Strengthen Your Bond With Your Dog

Retrieved on: 
Monday, April 19, 2021

The most important person in your dog\'s life is the person that gives them food!

Key Points: 
  • The most important person in your dog\'s life is the person that gives them food!
  • "It\'s made with turkey, beef, salmon, duck and nutrient-rich organ meats, so it will taste incredible to them, too.
  • Play and have fun together for at least 15 minutes to strengthen your connection with your dog.\nSimply cuddle.
  • Not that you needed an excuse, but cuddling can release the biochemical oxytocin for both you and your dog.

Fagron Sterile Services US (FSS) Launches Intravenous Bag Platform, Supports COVID-19 Medication Demand

Retrieved on: 
Tuesday, March 30, 2021

WICHITA, Kan., March 30, 2021 /PRNewswire/ -- Fagron Sterile Services US (FSS), a leader in 503B outsourcing, announces the continued expansion of its product portfolio with a new platform intravenous (IV) bags.

Key Points: 
  • WICHITA, Kan., March 30, 2021 /PRNewswire/ -- Fagron Sterile Services US (FSS), a leader in 503B outsourcing, announces the continued expansion of its product portfolio with a new platform intravenous (IV) bags.
  • These sterile medications have seen increased demand leading to drug shortages during the COVID-19 pandemic.
  • FSS continues to partner with healthcare facilities to meet outsourced medication needs, adding oxyTOCIN and NORepinephrine IV bags.
  • Fagron Sterile Services US (FSS), a top-tier DEA and FDA-registered 503B Outsourcing Provider, produces reliable supply of high-quality sterile medications with cGMP compliant operations to patient-focused healthcare facilities across North America.

Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)

Retrieved on: 
Thursday, February 11, 2021

The co-exclusive license allows Tonix to expand its intranasal potentiated oxytocin development program to a new indication.

Key Points: 
  • The co-exclusive license allows Tonix to expand its intranasal potentiated oxytocin development program to a new indication.
  • The new program at Tonix has the designation TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome.
  • Intranasal oxytocin improves suckling in newborn animals but also suppresses feeding behaviors in adult animal models.
  • As with any pharmaceutical under development, there are significant risks in the development, regulatory approval, and commercialization of new products.

ObsEva Provides Business Outlook for 2021

Retrieved on: 
Wednesday, February 10, 2021

The EDELWEISS 3 trial in the EU is progressing as planned, with primary endpoint data expected in Q4: 2021.

Key Points: 
  • The EDELWEISS 3 trial in the EU is progressing as planned, with primary endpoint data expected in Q4: 2021.
  • ObsEva remains strongly committed to developing linzagolix for endometriosis, for which better long-term treatments are still needed.
  • ObsEva is also developing nolasiban, an oral oxytocin receptor antagonist, to improve live birth rates in women undergoing in vitro fertilization.
  • ObsEva licensed Yselty from Kissei in late 2015 and retains worldwide commercial rights, excluding Asia, for the product.

5 Ways to Feel Connected Announced by Meetup, the Platform Proven to Increase Feelings of Connectedness

Retrieved on: 
Tuesday, January 26, 2021

Keep Connected is available on Spotify , Apple Podcasts , Google Podcasts and everywhere podcasts are found.

Key Points: 
  • Keep Connected is available on Spotify , Apple Podcasts , Google Podcasts and everywhere podcasts are found.
  • For the complete list of Five Ways to Feel More Connected, please visit: https://www.meetup.com/blog/five-ways-to-feel-more-connected/
    Eye Contact (Even on Zoom!)
  • -Making eye contact with anyone, including strangers, helps with an increase of oxytocin, a hormone known to improve mood and emotions.
  • Meetup has more than 52 million registered members across 330,000 groups in 193 countries and 10,000 cities around the world.

Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)

Retrieved on: 
Tuesday, December 22, 2020

This license allows Tonix to expand its intranasal potentiated oxytocin development program, TNX-1900, into cardiometabolic syndromes, which include insulin resistance, impaired glucose tolerance, and obesity.

Key Points: 
  • This license allows Tonix to expand its intranasal potentiated oxytocin development program, TNX-1900, into cardiometabolic syndromes, which include insulin resistance, impaired glucose tolerance, and obesity.
  • Our lead indication for TNX-1900 is for the treatment of migraine, said Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals.
  • Subsequent to the University of Geneva inventions, a number of studies have shown that intranasal oxytocin has effects on insulin resistance and weight2-4, continued Dr. Lederman.
  • In June 2020, Tonix acquired its potentiated oxytocin technology and development program from Trigemina, Inc., and assumed licenses for certain related technologies from Stanford University.

New Health Studies Suggest "Giggle Breaks" Are Key To Mitigating Stress During Pandemic

Retrieved on: 
Monday, December 21, 2020

The Mayo Clinic, a worldwide leader in medical care, endorses the heightened importance of oxytocin released through laughing to reduce stress, tension, pain and anxiety ( Stress relief from laughter?

Key Points: 
  • The Mayo Clinic, a worldwide leader in medical care, endorses the heightened importance of oxytocin released through laughing to reduce stress, tension, pain and anxiety ( Stress relief from laughter?
  • Morrison's newly released book, Torts "R" Us provides just that smiles for a stretch of time.
  • "I wrote the book because humor plays a role, even in the darkest of times," said Morrison.
  • Timed appropriately for the holidays and for many still sheltering-in place, the book is one antidote for improving good health.

ObsEva SA to present at The International Society of Gynecological Endocrinology 19th World Congress – virtual edition, December 2-5, 2020

Retrieved on: 
Tuesday, December 1, 2020

Dr Loumayes presentation will take place during the symposium available on demand on Friday December 4th from 08:00 am GMT and accessible for 4 months.

Key Points: 
  • Dr Loumayes presentation will take place during the symposium available on demand on Friday December 4th from 08:00 am GMT and accessible for 4 months.
  • ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health and pregnancy.
  • Nolasiban (previously known as OBE001), is an oral oxytocin receptor antagonist which was licensed from Merck KGaA, Darmstadt, Germany, in 2013.
  • These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements.

Therapy Dogs Offer New Fibromyalgia Management Option

Retrieved on: 
Wednesday, August 19, 2020

The National Fibromyalgia Association estimates 10 million Americans and between 3 and 6 percent of the world population suffers from fibromyalgia.

Key Points: 
  • The National Fibromyalgia Association estimates 10 million Americans and between 3 and 6 percent of the world population suffers from fibromyalgia.
  • For both patients and the therapy dogs, researchers used multiple non-invasive physiological biomarkers, including salivary oxytocin and cortisol concentrations, tympanic membrane temperatures and various cardiac parameters.
  • People who interacted with therapy dogs saw their oxytocin levels increase significantly, while their heart rates decreased.
  • Despite the widespread use of therapy dogs in clinical settings, there's a lack of understanding of the impact of animal-assisted activity sessions on the emotional state of the dogs.